9
Participants
Start Date
December 20, 2019
Primary Completion Date
December 30, 2022
Study Completion Date
December 30, 2022
Carrimycin
The study involves three dose groups: 200mg, 400mg and 600mg. Three patients are planned for each dose group. Starting from the low dose group, the treatment to three patients in the 200mg dose group: 200mg of Carrimycin after meals every morning (po) for three weeks, and then discontinue for one week, the tolerance and efficacy evaluation will be performed after the 4 weeks. DLT will be recorded during the 4 weeks.
Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai
Shanghai Jiao Tong University School of Medicine
OTHER